Mitchell M. Wong, Obviousness and Pharmaceutical Patents, 6 PHARM. L. & INDUS. REP.
525 (BNA May 2, 2008).
Mitchell M. Wong, The FDA Recognizes Loophole in the Forfeiture Provisions For A
First ANDA Applicant’s 180-Day Exclusivity, 6 PHARM. L. & INDUS. REP. 371 (BNA Mar.
Mitchell M. Wong, Outside Counsel Column, Patents: Personal Jurisdiction, Cease and
Desist Letters, 237 N.Y.L.J., Jun. 22, 2007, at 4.
Mitchell M. Wong, Outside Counsel Column, Forum Non Conveniens: Circumstances After
“Sinochem,” 237 N.Y.L.J., Mar. 27, 2007, at 4 (originally entitled The Doctrine of
Forum Non Conveniens After Sinochem).
Mitchell M. Wong, Making ’Em Pay—Literally: Cost Shifting in Electronic Discovery,
in ELECTRONIC EVIDENCE: BE PREPARED FOR CHANGES IN THE MATRIX, at C1 (NYSBA 2006).
Mitchell M. Wong, Note, The Aesthetic Functionality Doctrine and the Law of Trade
Dress Infringement, 83 CORNELL L. REV. 1116 (1998), reprinted in NEW YORK INTELLECTUAL
PROPERTY LAW ASSOCIATION, 1998 INTELLECTUAL PROPERTY LAW ANNUAL 349 (1999).
HONORS RECEIVED FOR THIS PUBLICATION:
►1998 Gerald Rose Memorial Award for Best Paper in Intellectual Property (Center
for Intellectual Property, John Marshall Law School, Chicago, IL)
►1998 John R. Brown Award for Excellence in Legal Writing (John R. Brown Foundation,
►First-Place Winner, 1998 William C. Conner Writing Competition (New York Intellectual
Property Law Association, New York City, NY)